LEECO CONCEP-7-BHCG (EIA) II (MODIFIED)

Agglutination Method, Human Chorionic Gonadotropin

LEECO DIAGNOSTICS, INC.

The following data is part of a premarket notification filed by Leeco Diagnostics, Inc. with the FDA for Leeco Concep-7-bhcg (eia) Ii (modified).

Pre-market Notification Details

Device IDK861703
510k NumberK861703
Device Name:LEECO CONCEP-7-BHCG (EIA) II (MODIFIED)
ClassificationAgglutination Method, Human Chorionic Gonadotropin
Applicant LEECO DIAGNOSTICS, INC. 21705 EVERGREEN P.O. BOX 5126 Southfield,  MI  48075
ContactJames Lee
CorrespondentJames Lee
LEECO DIAGNOSTICS, INC. 21705 EVERGREEN P.O. BOX 5126 Southfield,  MI  48075
Product CodeJHJ  
CFR Regulation Number862.1155 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1986-05-05
Decision Date1986-07-29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.